SOX2 and neoplasm: It is therefore hypothesized that activation of specific core transcriptional regulators that are normally active in ES cells, such as SOX2 and OCT4 and their downstream target genes such as NANOG and DPPA2, might afford tumor cells the ability to undergo dedifferentiation and reactivation of a specific developmental program, including vasculogenesis.